Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wei

Showing results (341-350 of 348) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 348 results.
Blood|May 27, 2008
Cyproheptadine displays preclinical activity in myeloma and leukemiaXinliang Mao, Sheng-ben Liang, Rose Hurren, et al.
Leukemia|June 10, 2018
Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemiaSamir H Barghout, Parasvi S Patel, Xiaoming Wang, et al.
Journal of Medicinal Chemistry|February 24, 2007
Design, synthesis, and activity of 2-imidazol-1-ylpyrimidine derived inducible nitric oxide synthase dimerization inhibitorsDavid D Davey, Marc Adler, Damian Arnaiz, et al.
Blood|April 17, 2020
Mitochondrial carrier homolog 2 is necessary for AML survivalDilshad H Khan, Michael Mullokandov, Yan Wu, et al.
Osteoarthritis and Cartilage Open|January 16, 2026
Identification of alkaline phosphatase as a putative biomarker of anti-NGF treatment-associated arthropathies: Machine learning-assisted analyses of clinical trial dataMatthew F Wipperman, Peter J Ehmann, Debra A G McIntyre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2016
What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)A Drilon, G Li, S Dogan, et al.
Cell Stem Cell|April 2, 2019
The Mitochondrial Transacylase, Tafazzin, Regulates for AML Stemness by Modulating Intracellular Levels of PhospholipidsAyesh K Seneviratne, Mingjing Xu, Juan J Aristizabal Henao, et al.
Cell Stem Cell|June 8, 2019
The Mitochondrial Transacylase, Tafazzin, Regulates AML Stemness by Modulating Intracellular Levels of PhospholipidsAyesh K Seneviratne, Mingjing Xu, Juan J Aristizabal Henao, et al.
Pageof 35

Showing results (341-350 of 348) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 348 results.
Blood|May 27, 2008
Cyproheptadine displays preclinical activity in myeloma and leukemiaXinliang Mao, Sheng-ben Liang, Rose Hurren, et al.
Leukemia|June 10, 2018
Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemiaSamir H Barghout, Parasvi S Patel, Xiaoming Wang, et al.
Journal of Medicinal Chemistry|February 24, 2007
Design, synthesis, and activity of 2-imidazol-1-ylpyrimidine derived inducible nitric oxide synthase dimerization inhibitorsDavid D Davey, Marc Adler, Damian Arnaiz, et al.
Blood|April 17, 2020
Mitochondrial carrier homolog 2 is necessary for AML survivalDilshad H Khan, Michael Mullokandov, Yan Wu, et al.
Osteoarthritis and Cartilage Open|January 16, 2026
Identification of alkaline phosphatase as a putative biomarker of anti-NGF treatment-associated arthropathies: Machine learning-assisted analyses of clinical trial dataMatthew F Wipperman, Peter J Ehmann, Debra A G McIntyre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2016
What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)A Drilon, G Li, S Dogan, et al.
Cell Stem Cell|April 2, 2019
The Mitochondrial Transacylase, Tafazzin, Regulates for AML Stemness by Modulating Intracellular Levels of PhospholipidsAyesh K Seneviratne, Mingjing Xu, Juan J Aristizabal Henao, et al.
Cell Stem Cell|June 8, 2019
The Mitochondrial Transacylase, Tafazzin, Regulates AML Stemness by Modulating Intracellular Levels of PhospholipidsAyesh K Seneviratne, Mingjing Xu, Juan J Aristizabal Henao, et al.
Pageof 35